BioCentury
ARTICLE | Clinical News

PCK3145: Phase IIa data

June 13, 2005 7:00 AM UTC

Data from an open-label, dose-escalation, U.K. Phase IIa trial in 16 patients showed 7 patients had stable disease and 1 patient had a partial response after 2 cycles of treatment with IV PCK3145. A r...